Journal article
Rheumatologic Medication Use During Pregnancy
Obstetrics and gynecology (New York. 1953), Vol.135(5), pp.1161-1176
05/2020
DOI: 10.1097/AOG.0000000000003755
PMCID: PMC8928214
PMID: 32282595
Abstract
Chronic rheumatic diseases often occur in women of reproductive age, and the effect rheumatic disease has on pregnancy varies depending on the condition. Medical management of rheumatic diseases during pregnancy may prevent joint or organ damage and minimize the adverse effects of the disease itself on pregnancy outcomes. Each patient requires individual assessment to control disease activity while minimizing or avoiding medications with potential maternal or fetal toxicity. An open discussion with shared decision making between patients, obstetricians, rheumatologists, and pharmacists is imperative to create an individualized treatment plan that meets patients' goals. This article will review the current literature for use of disease modifying antirheumatic drugs and biologics during pregnancy and lactation, providing health care professionals with the most up-to-date information available.
Details
- Title: Subtitle
- Rheumatologic Medication Use During Pregnancy
- Creators
- Emily A Peterson - University of Iowa Hospitals and ClinicsJessica LyntonAllison BernardMark K SantillanBrittany Bettendorf
- Resource Type
- Journal article
- Publication Details
- Obstetrics and gynecology (New York. 1953), Vol.135(5), pp.1161-1176
- DOI
- 10.1097/AOG.0000000000003755
- PMID
- 32282595
- PMCID
- PMC8928214
- NLM abbreviation
- Obstet Gynecol
- ISSN
- 0029-7844
- eISSN
- 1873-233X
- Grant note
- R01 HD089940 / NICHD NIH HHS
- Language
- English
- Date published
- 05/2020
- Academic Unit
- Obstetrics and Gynecology; Immunology; Internal Medicine
- Record Identifier
- 9984318227602771
Metrics
20 Record Views